Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q4LDE5: Variant p.Phe3161Ile

Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
Gene: SVEP1
Feedback?
Variant information Variant position: help 3161 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Phenylalanine (F) to Isoleucine (I) at position 3161 (F3161I, p.Phe3161Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 3161 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 3571 The length of the canonical sequence.
Location on the sequence: help ESEVKLRCLEGYTMDTDTDT F TCQKDGRWFPERISCSPKKC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         ESEVKLRCLEGYTMDTDTDTFTCQKDGRWFPERISCSPKKC

Mouse                         ESKVKLRCLEGYVMDSDTDTFTCQQDGHWVPERITCSPKKC

Rat                           ESKVKLRCLEGYVVDTDTDTFTCQQDGRWFPERINCSPKTC

Zebrafish                     GSKAQYRCKEGFELATKTDSITCQSDGTWSKHGVRCRPSPC

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 18 – 3571 Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
Domain 3120 – 3178 Sushi 29
Disulfide bond 3122 – 3163
Disulfide bond 3148 – 3176
Alternative sequence 869 – 3571 Missing. In isoform 2.
Alternative sequence 1547 – 3571 Missing. In isoform 4.



Literature citations
The full-ORF clone resource of the German cDNA consortium.
Bechtel S.; Rosenfelder H.; Duda A.; Schmidt C.P.; Ernst U.; Wellenreuther R.; Mehrle A.; Schuster C.; Bahr A.; Bloecker H.; Heubner D.; Hoerlein A.; Michel G.; Wedler H.; Koehrer K.; Ottenwaelder B.; Poustka A.; Wiemann S.; Schupp I.;
BMC Genomics 8:399-399(2007)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2131-3571; VARIANT ILE-3161;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.